
7.07 Delayed Data As of Sep 29 | ![]() Today’s Change | 6.62 Today|||52-Week Range 14.50 | -38.41% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $1.3B |
BioCryst Pharmaceuticals, Inc. 4505 Emperor Boulevard Durham North Carolina 27703-8457 |
Jon P. Stonehouse | President, Chief Executive Officer & Director |
Michael L. Jones | Executive Director-Finance |
Anthony Doyle | Chief Financial & Accounting Officer |
Helen M. Thackray | Chief Research & Development Officer |
Ryan Arnold | Chief Medical Officer |